Liang Z - Search Results

1

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.

Opat S, Tedeschi A, Hu B, Linton KM, McKay P, Leitch S, Coleman M, Zinzani PL, Jin J, Sun M, Sobieraj-Teague M, Browett P, Ke X, Thieblemont C, Ardeshna K, Bijou F, Walker P, Hawkes EA, Ho SJ, Zhou K, Liang Z, Xu J, Tankersley C, Delarue R, Co M, Trotman J. Opat S, et al. Among authors: liang z. Blood Adv. 2023 Nov 28;7(22):6801-6811. doi: 10.1182/bloodadvances.2023010668. Blood Adv. 2023. PMID: 37682792 Free PMC article. Clinical Trial.

2

Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma.

Liang Z, Li P, Kang L, Zhou L, Xu Y, Ye S, Du J, Li B, Wang Y, Yu L, Qian W, Liang A. Liang Z, et al. Among authors: liang a. Blood Adv. 2022 Jan 11;6(1):293-296. doi: 10.1182/bloodadvances.2021005814. Blood Adv. 2022. PMID: 34758063 Free PMC article. No abstract available.

3

Spleen-targeted delivery systems and strategies for spleen-related diseases.

Huang Z, Sun K, Luo Z, Zhang J, Zhou H, Yin H, Liang Z, You J. Huang Z, et al. Among authors: liang z. J Control Release. 2024 May 9:S0168-3659(24)00291-8. doi: 10.1016/j.jconrel.2024.05.007. Online ahead of print. J Control Release. 2024. PMID: 38734313 Review.

4

Structural transitions enable interleukin-18 maturation and signaling.

Dong Y, Bonin JP, Devant P, Liang Z, Sever AIM, Mintseris J, Aramini JM, Du G, Gygi SP, Kagan JC, Kay LE, Wu H. Dong Y, et al. Among authors: liang z. Immunity. 2024 May 8:S1074-7613(24)00220-6. doi: 10.1016/j.immuni.2024.04.015. Online ahead of print. Immunity. 2024. PMID: 38733997

5

A novel electrochemical aptasensor based on AgPdNPs/PEI-GO and hollow nanobox-like Pt@Ni-CoHNBs for procymidone detection.

Wang R, He B, Wang Y, Liu Y, Liang Z, Jin H, Wei M, Ren W, Suo Z, Xu Y. Wang R, et al. Among authors: liang z. Bioelectrochemistry. 2024 May 8;158:108728. doi: 10.1016/j.bioelechem.2024.108728. Online ahead of print. Bioelectrochemistry. 2024. PMID: 38733721

6

Research progress on the quality control of mRNA vaccines.

Hu C, Bai Y, Liu J, Wang Y, He Q, Zhang X, Cheng F, Xu M, Mao Q, Liang Z. Hu C, et al. Among authors: liang z. Expert Rev Vaccines. 2024 May 11. doi: 10.1080/14760584.2024.2354251. Online ahead of print. Expert Rev Vaccines. 2024. PMID: 38733272 Review.

7

Long non-coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT/β-catenin/PDK1 axis.

Su M, Liang Z, Shan S, Gao Y, He L, Liu X, Wang A, Wang H, Cai H. Su M, et al. Among authors: liang z. Cancer Med. 2024 May;13(9):e7221. doi: 10.1002/cam4.7221. Cancer Med. 2024. PMID: 38733179 Free PMC article.

8

Porous Organic Framework Materials (MOF, COF, and HOF) as the Multifunctional Separator for Rechargeable Lithium Metal Batteries.

Yang Y, Sun Z, Wu Y, Liang Z, Li F, Zhu M, Liu J. Yang Y, et al. Among authors: liang z. Small. 2024 May 10:e2401457. doi: 10.1002/smll.202401457. Online ahead of print. Small. 2024. PMID: 38733086 Review.

9

Synthesis of Nano-Structured Conjugated Polymers with Multiple Micro-/Meso-Pores by the Post-Crosslinking of End-Functionalized Hyperbranched Conjugated Polymers.

Liang Z, Liang H. Liang Z, et al. Polymers (Basel). 2024 Apr 24;16(9):1192. doi: 10.3390/polym16091192. Polymers (Basel). 2024. PMID: 38732661

10

Recent advances of multifunctional zwitterionic polymers for biomedical application.

Lv W, Wang Y, Fu H, Liang Z, Huang B, Jiang R, Wu J, Zhao Y. Lv W, et al. Among authors: liang z. Acta Biomater. 2024 May 8:S1742-7061(24)00246-0. doi: 10.1016/j.actbio.2024.05.006. Online ahead of print. Acta Biomater. 2024. PMID: 38729548 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,162 results

Search Page